New diabetes clinical trial: Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

Published on: 2026-09-04T04:00:00Z
Conditions: Overweight , Obesity; Type 2 Diabetes Mellitus (T2DM); MASH - Metabolic Dysfunction-Associated Steatohepatitis
Interventions: Drug: MWN105 1; Drug: MWN105 2; Drug: MWN105 3; Drug: Placebo
Sponsors: Shanghai Minwei Biotechnology Co., Ltd
Recruiting
https://ift.tt/cVNS6wi